AstraZeneca
AZN
#44
Rank
NZ$531.52 B
Marketcap
NZ$342.86
Share price
-2.18%
Change (1 day)
28.02%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): NZ$9.08

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$9.00. In 2024 the company made an earnings per share (EPS) of NZ$7.63 an increase over its 2023 EPS that were of NZ$6.46.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$9.0818.92%
2024NZ$7.6318.23%
2023NZ$6.4681.13%
2022NZ$3.56631.03%
2021NZ$0.49-88.11%
2020NZ$4.10136.89%
2019NZ$1.73-39.41%
2018NZ$2.86-28.27%
2017NZ$3.99-14.37%
2016NZ$4.6524.11%
2015NZ$3.75127.55%
2014NZ$1.65-51.96%
2013NZ$3.43-58.95%
2012NZ$8.36-32.2%
2011NZ$12.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.73 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.38 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.29-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.30-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.71 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.47-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.48 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.29 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.99-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.34-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK